Fusion Protein Engineering And Developability Summit 2023, Boston, Massachusetts, United States Wyndham Boston Beacon Hill, Boston

Prepare to be captivated by the Fusion Protein Engineering and Developability Summit, the ultimate event tailored to drug developers with ground-breaking fusion protein pipelines. This conference is an absolute game-changer that should be at the top of your priority list!

As the demand for practical and effective engineering techniques to expedite the development of viable drugs into clinical applications skyrockets, this highly anticipated summit offers an unrivalled opportunity. Join forces with esteemed experts from industry giants like Roche, Merck, Bristol Myers Squibb, Abbvie, and an array of other distinguished names. Seize this unique occasion to connect with fellow drug developers, exchange innovative ideas and strategies, and gain invaluable insights into cutting-edge fusion applications.

Prepare for a whirlwind of activity across the action-packed three-day agenda, including:
. Cutting-Edge Insights: Gain exclusive access to the latest breakthroughs in fusion protein engineering, encompassing the most recent research and emerging trends in this dynamic field.
. Practical Learning: Immerse yourself in hands-on workshops led by industry experts, designed to enhance your skills and knowledge in must-know areas.
. Real-World Case Studies: Immerse yourself in over 17+ data-driven case studies presented by renowned drug developers, offering profound insights and best practices.
. Engaging Discussions: Engage in lively panel discussions and roundtable sessions, fostering debates and knowledge exchange on hot topics such as novel linker selection and the identification of PK/PD rules.
. Networking Opportunities: Forge valuable connections with 60+ protein engineers, therapeutic developers, and influential industry leaders during 7+ hours of dedicated networking, including the renowned speed networking session.

With a stellar lineup of 25+ speakers, 3 immersive hands-on workshops, and 2 days packed with data-driven case studies, this event is set to become the unequivocal highlight of the year and you cannot afford to miss it!

Speakers: Basil Golding, Office Director, FDA, Hilmar Ebersbach, SVP Antibody Development and Protein Engineering, Immunos Therapeutics, Medha Tomlinson, Director – Global Biologics Research, Takeda, Naresh Chennamsetty, Associate Scientific Director, Bristol Myers Squibb, Ramkrishna Sadhukhan, Head of Cell, Gene, and Protein Engineering, Biotherapeutics, AbbVie, Rosa Grenha, Principal Scientist – Molecular Discovery, Merck and Co, Abhinav Gupta, Senior Machine Learning Scientist, Sanofi, Christian Klein, Head of Cancer Immunotherapy Discovery Oncology Programs and Department, Roche, Daniel Serna, Principal Research Scientist, AbbVie, Even Walseng, Associate Director, AstraZeneca